ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Magnetic resonance imaging (MRI)"

  • Abstract Number: 0401 • ACR Convergence 2024

    Biologic Abatement and Capturing Kids Outcomes and Flare Frequency in Juvenile Spondyloarthritis: Baseline Characteristics and Enrollment

    Cora Sears1, Cassandra Muir1, Timothy Brandon1, Polly Ferguson2, Colleen Correll3, Margalit Rosenkranz4, Kevin Baszis5, Tzielan Lee6, Edward Oberle7, Matthew Stoll8, Kathryn Cook9, Eyal Muscal10, Hemalatha Srinivasalu11, Daniel Lovell12, Sampath Prahalad13, Michal Cidon14, Evan Mulvihill15, Marisa Klein-Gitelman16, Daniel Kingsbury17, Jennifer Cooper18, Natalie Rosenwasser19, Erin Treemarcki20, Joyce Chang21, Stacey Tarvin22, Heather Walters23, Michael Shishov24, Lisa Buckley25, Mary Toth26, Ashley Cooper27, Rui Xiao28, Emily Neu29, Melanie Kohlheim30, Jenny Leal31, Kweli Archie32, English Holland33, Miles Holland34, Aamena Hameed35, Asad Khan36, Lynn Murphy37, Sean Murphy38, Justin Neu29, Rachel Richmond39, Dylan Suplee40, Theresa Suplee41, Dawn Wiley42 and Pamela Weiss43, 1Children's Hospital of Philadelphia, Philadelphia, PA, 2University of Iowa Carver College of Medicine, Iowa City, IA, 3University of Minnesota, Minneapolis, MN, 4UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, 5Washington Univ in St. Louis School of Medicine, St Louis, MO, 6Stanford University School of Medicine, Palo Alto, CA, 7Nationwide Children's Hospital, Columbus, OH, 8University of Alabama at Birmingham, Birmingham, AL, 9Akron Children's Hospital, Akron, OH, 10Baylor College of Medicine, Houston, TX, 11Children's National Hospital, Washington, DC, 12Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 13Emory + Children's Pediatric Institute, Atlanta, GA, 14Children's Hospital of Los Angeles, Los Angeles, CA, 15Nemours/A.I.duPont Hospital for Children, Wilmington, DE, 16Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 17Legacy Health, Portland, OR, 18University of Colorado/Children's Hospital Colorado, Aurora, CO, 19Seattle Children's Hospital, Seattle, WA, 20University of Utah, Salt Lake City, UT, 21Boston Children's Hospital, Boston, MA, 22Indiana University School of Medicine, Indianapolis, IN, 23Northwell Health, New Hyde Park, NY, 24Phoenix Children's Hospital, Phoenix, AZ, 25Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN, 26Nemours Foundation, Orlando, FL, 27Children's Mercy Kansas City, Kansas City, MO, 28University of Pennsylvania, Philadelphia, PA, 29Parent Partner, Sidney, OH, 30Parent Partner, Granville, OH, 31Parent Partner, Columbus, OH, 32Parent Partner, Philadelphia, PA, 33Parent Partner, Williamsburg, VA, 34Patient Partner, Williamsburg, VA, 35Parent Partner, Franklin Park, NJ, 36Patient Partner, Franklin Park, NJ, 37Parent Partner, Haddon Heights, NJ, 38Patient Partner, Haddon Heights, NJ, 39Parent Partner, Albuquerque, NM, 40Patient Partner, Maple Shade, NJ, 41Parent Partner, Maple Shade, NJ, 42Parent Partner, Downingtown, PA, 43Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Inactive disease is the goal for youth with spondyloarthritis (SpA).  Many patients are interested in stopping medications after inactive disease is achieved. The risk…
  • Abstract Number: 1445 • ACR Convergence 2024

    Systematic Characterization of MRI Lesions Per ASAS Definitions in the Sacroiliac Joints of Patients with Axial Spondyloarthritis and Comparisons Among Subgroups with Psoriasis, Iritis, Colitis, AxSpA Alone, and Matched Back Pain Controls

    Ulrich Weber1, Susanne Pedersen2, Ozun Bayindir Tsechelidis3, Robert Lambert4, Joel Paschke5, Stephanie Wichuk4 and Walter Maksymowych4, 1Practice Buchsbaum Schaffhausen, Schaffhausen, Switzerland, 2Rigshospitalet, København, Denmark, 3Ottawa University, Ottawa, ON, Canada, 4University of Alberta, Edmonton, AB, Canada, 5CARE Arthritis, Edmonton, AB, Canada

    Background/Purpose: There is limited information on the frequency and topographical distribution of MRI lesions in the sacroiliac joints (SIJ) of patients with axSpA according to…
  • Abstract Number: 0574 • ACR Convergence 2024

    14-3-3 Eta (η) Auto-Antibody as a Diagnostic Marker in Axial Spondyloarthritis: A Longitudinal Study

    Anthony Marotta1, Walter Maksymowych2, Stephanie Wichuk2 and Navneet Sidhu1, 1Augurex Life Sciences Corp, Vancouver, BC, Canada, 2University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Diagnosis of axial spondyloarthritis (AxSpA) is challenging and often delayed primarily due to the lack of sensitive and specific markers needed for accurate and…
  • Abstract Number: 1452 • ACR Convergence 2024

    Assessing Responsiveness of Outcome Measures for Children with Axial Juvenile Spondyloarthritis (JSpA)

    Timothy Brandon1, Rui Xiao2, Cassandra Muir1, Matthew Stoll3, Daniel Lovell4, Edward Oberle5, Nancy Chauvin6, Michael Francavilla7, Walter Maksymowych8 and Pamela Weiss9, 1Children's Hospital of Philadelphia, Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA, 3University of Alabama at Birmingham, Birmingham, AL, 4Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 5Nationwide Children's Hospital, Columbus, OH, 6The Imaging Institute @ The Cleveland Clinic, Cleveland, OH, 7Department of Radiology, Whiddon College of Medicine, University of South Alabama, Mobile, AL, 8University of Alberta, Edmonton, AB, Canada, 9Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Trials for patients with juvenile spondyloarthritis (JSpA) and axial disease are scarce. We assessed the responsiveness of measures for use in trials of patients…
  • Abstract Number: 0656 • ACR Convergence 2024

    Lupus Myocarditis: Clinical Characteristics, Cardiac Magnetic Resonance Imaging Findings and Outcomes

    María del Carmen Zamora-Medina1, Erik Cimé-Aké2, Emilio G. Lazarini2, Wallace Rafael A. Muñoz-Castañeda3 and Hilda Fragoso-Loyo2, 1Instituto Nacional de Perinatología "Isidro Espinoza de los Reyes". Rheumatology Department, Mexico City, Distrito Federal, Mexico, 2Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Immunology and Rheumatology Department, Mexico City, Mexico, 3Hospital Medica Sur. Rheumatology Department, Mexico City, Distrito Federal, Mexico

    Background/Purpose: Limited information about lupus myocarditis (LM) comes from small case series. The aim of our study is to describe and compare clinical characteristics, cardiac…
  • Abstract Number: 1478 • ACR Convergence 2024

    Associations Between Clinical Characteristics and Screening MRI Findings: Exploratory Analysis of the Ongoing Phase 4, Multicenter, Randomized, Controlled STAR Study of Biologic-Naïve Patients with PsA with MRI-Confirmed Axial Involvement

    Xenofon Baraliakos1, Paul Bird2, Atul Deodhar3, Dafna Gladman4, Philip S. Helliwell5, Denis Poddubnyy6, Arthur Kavanaugh7, Mikkel Ostergaard8, Enrique R. Soriano9, Lai-shan Tam10, Soumya Chakravarty11, Evan Leibowitz12, Cinty Gong13, Stephen Xu14, Thomas Fuerst15, Nadeem Saeed16, Robert Landewé17 and Philip Mease18, 1Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 2University of New South Wales, Randwick, NSW, Sydney, New South Wales, Australia, 3Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, Portland, OR, 4University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 5Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK, Leeds, United Kingdom, 6Charite-Universitatsmedizin Berlin, Berlin, Germany, 7University of California San Diego, La Jolla, CA, 8Department of Clinical Medicine, University of Copenhagen and Center for Rheumatology, Copenhagen Center for Arthritis Research, Glostrup, Denmark, 9Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 10The Chinese University of Hong Kong, New Territories, Hong Kong, 11Janssen Scientific Affairs, LLC, Horsham/ Drexel University College of Medicine, Philadelphia, Horsham, PA, 12Janssen Scientific Affairs, LLC, Fair Lawn, NJ, 13Janssen Scientific Affairs, Horsham, PA, 14Janssen Research & Development, LLC, Spring House, PA, USA, Spring House, PA, 15Clario, San Mateo, CA, 16Clario, San Mateo, 17Amsterdam University Medical Center, Meerssen, Netherlands, 18Swedish Medical Center/Providence St. Joseph Health; University of Washington School of Medicine, Seattle, WA

    Background/Purpose: Patients (pts) with PsA can develop axial inflammation in the SI joints (SIJs) and/or spine. Although validated classification criteria for axial spondyloarthritis exist, established…
  • Abstract Number: 0683 • ACR Convergence 2024

    Prognostic Value of Systemic Sclerosis-associated Primary Heart Involvement

    Caya Gharibian1, Vanessa Lupi1, Alexander Gotschy1, Mike Becker2, Rucsandra Dobrota1, Muriel Elhai3, Sinziana Muraru1, Suzana Jordan1, Anna-Maria Hoffmann-Vold4, Oliver Distler5, Robert Manka1, Cosimo Bruni1 and Carina Mihai1, 1University Hospital Zurich, University of Zurich, Zurich, Switzerland, 2Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zürich, Switzerland, 3University Hospital zurich, Zürich, Switzerland, 4Oslo University Hospital, Oslo, Norway, 5Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, Zurich, Switzerland

    Background/Purpose: A definition of primary heart involvement (pHI) in systemic sclerosis (SSc) was recently developed (Bruni C et al. J Scleroderma Relat Disord. 2022;7:24-32). Cardiac…
  • Abstract Number: 1635 • ACR Convergence 2024

    Magnetic Resonance Imaging for Therapy Monitoring in Giant Cell Arteritis – Impact on Disease Management

    Matthias Froehlich1, Michael Gernert2, Marc Schmalzing3, Patrick-Pascal Strunz4, Hanna Labinsky5, Thorsten A. Bley6 and Konstanze V. Guggenberger6, 1Uniklinikum Wuerzburg, Medizinische Klinik II, Wuerzburg, Germany, 2Medicine II, Division Rheumatology/Clinical Immunology, University Hospital of Wuerzburg, Wuerzburg, 3University Hospital Wuerzburg, Würzburg, Germany, 4University hospital of Wuerzburg, Wuerzburg, Germany, 5University Hospital Würzburg, Wuerzburg, Germany, 6University Hospital Würzburg, Würzburg, Germany

    Background/Purpose: Imaging techniques such as magnetic resonance imaging (MRI) are a cornerstone for the diagnosis of giant cell arteritis (GCA). In the further course of…
  • Abstract Number: 0689 • ACR Convergence 2024

    Arrhythmic Burden, Myocardial Markers, and Long-term Survival in Distinct Cardiac Magnetic Resonance Subsets of Systemic Sclerosis

    Silvia Laura Bosello1, Enrico De Lorenzis2, Giacomo De Luca3, Antonio Tonutti4, veronica Batani5, Pier Giacomo Cerasuolo6, Gerlando Natalello7, Lucia Lanzo6, Gabriella Alonzi6, Silvia Fiore6, Stefano Di Murro6, Andrea Zoli6, Valentina Boni6, Riccardo Marano8, Francesca Augusta Gabrielli9, Francesco Del Galdo10, Dan Knight11, Vivek Muthurangu11, Christopher Denton12, Maria De Santis4, Marco Matucci Cerinic5 and Maria Antonietta D'Agostino13, 1Unit of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy, 2Catholic University of the Sacred Heart, Roma, Rome, Italy, 3Vita-Salute San Raffaele University & IRCCS San Raffaele Hospital, Milan, Milan, Italy, 4Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Rozzano, Italy, 5Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy, 6Division of Rheumatology, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 7Division of Rheumatology - Catholic University of the Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Rome, Italy, 8Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Diagnostic Imaging Area, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy, 9Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 10University of Leeds, Leeds, United Kingdom, 11UCL Department of Cardiac MRI, University College London (Royal Free Campus), London, United Kingdom, 12University College London, Northwood, United Kingdom, 13Division of Rheumatology, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Università Cattolica del Sacro Cuore, Rome, Italy

    Background/Purpose: Cardiac involvement in Systemic Sclerosis (SSc) is widely recognized as heterogeneous and, when clinically evident, it is associated with a poor prognosis. Recently, five…
  • Abstract Number: 1757 • ACR Convergence 2024

    Bimekizumab Treatment Resulted in Improvements in MRI Inflammatory and Structural Lesions in the Sacroiliac Joints of Patients with Axial Spondyloarthritis: 52-Week Results and Post Hoc Analyses from Two Phase 3 Studies

    Walter Maksymowych1, Sofia Ramiro2, Denis Poddubnyy3, Xenofon Baraliakos4, Robert Lambert1, Ute Massow5, Thomas Vaux6, Chetan Prajapati6, Alexander Marten5, Natasha de Peyrecave7 and Mikkel Ostergaard8, 1University of Alberta, Edmonton, AB, Canada, 2Leiden University Medical Center, Bunde, Netherlands, 3Charite-Universitatsmedizin Berlin, Berlin, Germany, 4Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 5UCB Pharma, Monheim am Rhein, Germany, 6UCB Pharma, Slough, United Kingdom, 7UCB Pharma, Brussels, Belgium, 8Department of Clinical Medicine, University of Copenhagen and Center for Rheumatology, Copenhagen Center for Arthritis Research, Glostrup, Denmark

    Background/Purpose: The impact of bimekizumab (BKZ), a monoclonal IgG1 antibody that selectively inhibits interleukin (IL)‑17F in addition to IL-17A, on structural lesions in patients (pts)…
  • Abstract Number: 0696 • ACR Convergence 2024

    MRI DAVIX Index Is an Imaging Biomarker for Endothelial Damage of Systemic Sclerosis Digital Ulcers

    Stefano Di Donato1, Rebecca Ross2, Yassir El-Sherbiny3, Riccardo Bixio4, Marco Minerba5, Christopher Wasson6, Jun Li7, Jochen SCHMITZ8, Sudha Visvanathan9 and Francesco Del Galdo6, 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Leeds, UK, Leeds, United Kingdom, 2Medicine and Health, University of Leeds, Leeds, United Kingdom, 3Nottingham Trent University, Nottingham, United Kingdom, 4University of Verona, Verona, Verona, Italy, 51. Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, 2. NIHR Leeds Biomedical Research Centre, United Kingdom, Leeds, United Kingdom, 6University of Leeds, Leeds, United Kingdom, 7Boehringer Ingelheim, Danbury, CT, 8Boehringer-Ingelheim, Ridgefield, CT, 9Boehringer-Ingelheim Pharmaceuticals, Ridgefield, CT

    Background/Purpose: Circulating endothelial cells (CEC) and their precursors have been shown to correlate to the severity of vascular manifestations in Systemic sclerosis1, such as Digital…
  • Abstract Number: 1957 • ACR Convergence 2024

    Assessing Left Ventricular Hemodynamic Forces in Systemic Sclerosis Patients: Pilot Study

    Aïcha Kante1, Andreea Afana2, Damien Sène3, Valérie Bousson4, Trecy Goncalves5, Edouard Ballout5, Solenn Toupin5, Jean-Guillaume Dillinger6, William Bigot3, Valentin Pagis7, Karine Champion3, Ruxandra burlacu7, stephane mouly3, Patrick Henry6, Theo Pezel6 and Cloé Comarmond3, 1Department of internal medicine, Centre de Compétence Maladies Rares autoimmunes et inflammatoires, Université Paris Cité, Paris, Ile-de-France, France, 2Department of Cardiology, University of Medicine and Pharmacy Craiova, Craiova, Romania, 3Department of internal medicine, Centre de Compétence Maladies Rares autoimmunes et inflammatoires, Lariboisière Hospital, Université Paris Cité, Paris, Ile-de-France, France, 4Department of Radiology, Lariboisiere Hospital, (Assistance Publique des Hôpitaux de Paris, AP-HP), Paris, Ile-de-France, France, 5Department of Cardiology, Lariboisiere Hospital, (Assistance Publique des Hôpitaux de Paris, AP-HP), Paris, France, 6Department of Cardiology, Lariboisiere Hospital, (Assistance Publique des Hôpitaux de Paris, AP-HP), Paris, Ile-de-France, France, 7Department of internal medicine, Centre de Compétence Maladies Rares autoimmunes et inflammatoires, Lariboisière Hospital, Université Paris Cité, Paris, France

    Background/Purpose: Systemic sclerosis (SSc) is a connective tissue disease marked by inflammation, microvascular changes and fibrosis. Cardiac comorbidities are the leading cause of mortality. Early…
  • Abstract Number: 0821 • ACR Convergence 2024

    Validation of ASAS Preliminary Data-Driven MRI Lesion Cut-offs for a Positive MRI of the Sacroiliac Joints in Patients with Axial Spondyloarthritis and Subgroups with Psoriasis, Iritis, and Colitis

    Susanne Pedersen1, Ulrich Weber2, Ozun Bayindir Tsechelidis3, Robert Lambert4, Joel Paschke5, Stephanie Wichuk4 and Walter Maksymowych4, 1Rigshospitalet, København, Denmark, 2Practice Buchsbaum Schaffhausen, Schaffhausen, Switzerland, 3Ottawa University, Ottawa, ON, Canada, 4University of Alberta, Edmonton, AB, Canada, 5CARE Arthritis, Edmonton, AB, Canada

    Background/Purpose: Recent analysis of MRI scans from the 2009 ASAS classification cohort has led to a new proposal for the application of more stringent MRI…
  • Abstract Number: 1958 • ACR Convergence 2024

    Hemodynamic Forces: A Novel Cardiac MRI Parameter to Assess Cardiac Involvement in Sarcoidosis Patients

    Aïcha Kante1, Andreea Afana2, Damien Sène3, Karine Champion3, Valentin Pagis4, William Bigot3, Véronique Delcey5, Amanda Lopes3, Abdellatif Tazi6, Blanca Amador Borrero4, Bruno Crestani7, Claire Baladi8, Valérie Bousson9, Trecy Goncalves10, Edouard Ballout10, Solenn Toupin10, stephane mouly3, Jean-Guillaume Dillinger11, Patrick Henry11, Theo Pezel11 and Cloé Comarmond3, 1Department of internal medicine, Centre de Compétence Maladies Rares autoimmunes et inflammatoires, Université Paris Cité, Paris, Ile-de-France, France, 2Department of Cardiology, University of Medicine and Pharmacy Craiova, Craiova, Romania, 3Department of internal medicine, Centre de Compétence Maladies Rares autoimmunes et inflammatoires, Lariboisière Hospital, Université Paris Cité, Paris, Ile-de-France, France, 4Department of internal medicine, Centre de Compétence Maladies Rares autoimmunes et inflammatoires, Lariboisière Hospital, Université Paris Cité, Paris, France, 5Department of Infectious diseases, Lariboisère University Hospital, Paris, Ile-de-France, France, 6National Reference Center for Histiocytoses, Department of Pulmonology, AP-HP, Saint-Louis Hospital, Paris, France, 7National Reference Center for Rare Pulmonary Diseases, Department of Pulmonology, AP-HP, Bichat Hospital, Paris, Ile-de-France, France, 8Université d’Angers, Department of Cardiology, University Hospital of Angers, Angers, France, 9Department of Radiology, Lariboisiere Hospital, (Assistance Publique des Hôpitaux de Paris, AP-HP), Paris, Ile-de-France, France, 10Department of Cardiology, Lariboisiere Hospital, (Assistance Publique des Hôpitaux de Paris, AP-HP), Paris, France, 11Department of Cardiology, Lariboisiere Hospital, (Assistance Publique des Hôpitaux de Paris, AP-HP), Paris, Ile-de-France, France

    Background/Purpose: Cardiac sarcoidosis (CS) is an underdiagnosed condition characterized by the formation of non-caseating granuloma in the myocardium, potentially leading to arrhythmia, acute heart failure,…
  • Abstract Number: 0852 • ACR Convergence 2024

    3-dimensional Shape Changes of the Knee over 4 Years Are Linear and Progressive but Much More Rapid in Osteoarthritic Joints: Data from the Osteoarthritis Initiative

    Alan Brett1, Philip G Conaghan2 and Michael Bowes3, 1Imorphics, Austin, TX, 2Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 3Imorphics, Manchester, United Kingdom

    Background/Purpose: The specific bony changes of osteophyte growth and “bone attrition” (broadening and flattening of the femoral condyles) associated with OA have been recognized in…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 24
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology